FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-29.95%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$366M
AUM Growth
–
Cap. Flow
+$366M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
7
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Seres Therapeutics
MCRB
|
$156M |
| 2 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$66.7M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$51M |
| 4 |
Editas Medicine
EDIT
|
$46.6M |
| 5 |
Cartesian Therapeutics
RNAC
|
$23.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 95.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Seres Therapeutics
MCRB
$166M
| $156M | 42.59% |
+12,682,876
| New | +$156M |
|
|
SYRS
2
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $66.7M | 18.22% |
+4,806,656
| New | +$66.7M |
|
|
3
Agios Pharmaceuticals
AGIO
$2.19B
| $51M | 13.93% |
+965,369
| New | +$51M |
|
|
4
Editas Medicine
EDIT
$231M
| $46.6M | 12.73% |
+3,455,316
| New | +$46.6M |
|
|
5
Cartesian Therapeutics
RNAC
$261M
| $23.5M | 6.43% |
+1,651,862
| New | +$23.5M |
|
|
TTOO
6
DELISTED
T2 Biosystems, Inc
TTOO
| $15.8M | 4.3% |
+2,176,167
| New | +$15.8M |
|
7
Carisma Therapeutics
CARM
$8.98M
| $6.59M | 1.8% |
+2,354,710
| New | +$6.59M |
|